Subscribe
Sign in
Home
News
Market Insights
Stocks
Strategy
Books
X-Articles
The BowtiedBiotech Podcast
Archive
Leaderboard
About
Market Insights
Latest
Top
Discussions
The Drug Supply Chain Is Running Out of Water | Ep. 1049
Europe’s drought is turning rivers, cooling systems, and industrial water into hidden constraints on therapeutic development
Aug 6
2
The Peptide Underground Is Running Biotech’s Cheapest Human Experiment | Ep. 1040
The FDA crackdown on compounded peptides could reveal the next real therapeutic platform hiding inside the wellness market.
Jul 23
2
1
The Discount Rate Is a Clinical Endpoint Now | Ep. 1034
How high rates, energy shocks, and expensive time are reshaping therapeutic development
Jul 9
1
China Built the Translation Layer While We Were Pricing Platforms | Ep. 1026
China biotech is not the future threat. It is already the BD pipeline
Jun 25
4
Why Biotech Returns Trail Scientific Progress | Ep. 1021
Better Biology, Worse Returns
Jun 18
3
1
The Hospital Is the Factory Now | Ep. 1012
Why in vivo CAR-T is the next real platform fight
Jun 12
2
Precision Medicine’s Scaling Problem | Ep. 997
The More We Learn About Disease, The Smaller the Markets Become
May 7
3
Gene Therapy’s Reality Check | Ep. 988
Curative Science Meets a Broken System
Apr 23
3
Why Mental Health Drug Development Keeps Failing | Ep. 983
That’s About to Break
Apr 17
5
1
The FDA Is Not the Bottleneck. Companies Are | Ep. 973
Execution fails. The FDA just reveals it.
Apr 2
5
1
The Cost of Capital Regime | Ep. 968
Why Biotech M&A Is Being Rewritten in Real Time
Mar 26
4
1
The Assets Pharma Actually Wants | Ep. 962
Why legible therapeutics now command the premium
Mar 19
11
1
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts